Tokyo, Japan

Takashi Dan


Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1985-1989

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Takashi Dan: Innovator in Pharmaceutical Chemistry

Introduction

Takashi Dan is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 5 patents to his name, Dan's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Among his latest patents, Dan has developed xanthone derivatives and a process for producing the same. These derivatives are characterized by a specific formula that includes various substituents, making them useful as diuretics with uricosuric activity. They can be employed in the treatment of edema or hypertension. Additionally, he has created novel furobenzisoxazole derivatives, which also exhibit hypotensive, uricosuric, and diuretic activities. These compounds are valuable for treating hyperuricemia, edema, and hypertension.

Career Highlights

Dan is currently associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at the company has allowed him to focus on innovative drug development, contributing to advancements in therapeutic options for patients.

Collaborations

Throughout his career, Dan has collaborated with notable colleagues, including Hiroshi Koga and Takashi Mori. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Takashi Dan's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work continues to pave the way for new therapeutic solutions, demonstrating the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…